Thai Health Ministry starts trial of LAAB drug in immunocompromised patients

13 Sept 07:13 Key points summarised by AI

The Thai Ministry of Public Health initiated trials of the Long Acting Antibody (LAAB) treatment, Evusheld, on three chronic kidney disease patients to boost their immunity against COVID-19.
Evusheld is intended for approximately 500,000 immunocompromised individuals in Thailand, including those with kidney disease, organ transplants, or on immunosuppressants, providing about six months of protection.
Thailand secured 257,500 doses of Evusheld from AstraZeneca through a vaccine exchange agreement, with 7,000 doses already received for immediate use.

Nationwide crackdown launched on illegal nominee shareholders and land holdings

Today 15:20 Key points summarised by AI

Thailand's Prime Minister Anutin Charnvirakul initiated a nationwide crackdown on illegal Thai nominee shareholders in foreign-run businesses and land holdings to safeguard national interests.
The government will integrate efforts across all relevant agencies to target illicit foreign operations, forced sales of illegally acquired property, and high-risk land ownership schemes.
Key strategies include auditing suspect land and building holdings, establishing a long-term monitoring system, and cross-referencing data from various authorities to trace ultimate beneficial owners.
Prime Minister Anutin emphasized that no influential figures or corrupt officials are above the law, promising straightforward prosecution, asset seizures, and protection for enforcing officers.
Beyond land ownership, the integrated crackdown will also extend to tackle transnational crimes, including drug and human trafficking.